Full Text View
Tabular View
No Study Results Posted
Related Studies
Golimumab Safety and Surveillance Program Using the Ingenix NHI Database
This study is ongoing, but not recruiting participants.
Study NCT01081717   Information provided by Janssen Biotech, Inc.

First Received on March 4, 2010.   Last Updated on May 30, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Rheumatoid Arthritis
Arthritis, Psoriatic
Ankylosing Spondylitis
Additional conditions recognized in this trial
Arthritis
Arthritis, Rheumatoid
Spondylitis
Spondylitis, Ankylosing
More general conditions related to this trial
Ankylosis
Autoimmune Diseases
Bone Diseases
Bone Diseases, Infectious
Connective Tissue Diseases
Immune System Diseases
Infection
Joint Diseases
Musculoskeletal Diseases
Psoriasis
Rheumatic Diseases
Skin Diseases
Skin Diseases, Papulosquamous
Spinal Diseases
Spondylarthritis
Spondylarthropathies
Interventions listed in this trial
systemic non-biological treatments
anti-TNF biologics
golimumab
non-anti-TNF biologics
general population
Sponsors listed in this trial
Janssen Biotech, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services